This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (8)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Dementias  • Neurogenetics  • Movement Disorders  • Parkinson Disease/ Parkinsonian Disorders  • Neurology, Other  • Nutritional and Metabolic Disorders  • Lipids and Lipid Disorders  • Genetic Disorders  • Alert me on articles by topic  Social Bookmarking   What's this?

Barbara Jasinska-Myga, MD, PhD; Grzegorz Opala, MD, PhD; Christopher G. Goetz, MD; Jerzy Tustanowski, MD, PhD; Stanislaw Ochudlo, MD, PhD; Agnieszka Gorzkowska, MD, MSc; Jadwiga Tyrpa, MSc

Arch Neurol. 2007;64(2):261-265.

Background  Apolipoprotein E gene (APOE) polymorphism is an important determinant for the development of various cardiovascular and neurodegenerative disorders. There have been conflicting reports of association of APOE polymorphism with dementia in Parkinson disease (PD).

Objective  To determine the relationship between APOE polymorphisms and plasma cholesterol concentration, and PD with dementia (PDD).

Design  Four-year (1999-2002) case-control study.

Setting  Academic medical center with inpatient and outpatient movement disorders services.

Patients  Consecutive white patients of the same ethnic background with PD.

Interventions  Strict clinical, neuropsychological, and neuroimaging criteria were used to exclude dementia with Lewy bodies, Alzheimer disease, and vascular dementia. Findings were compared in 2 clinical groups, including 98 patients (47 men and 51 women; mean age, 71 years) with PDD and 100 patients (52 men and 48 women; mean age, 62 years) with PD without dementia.

Main Outcome Measures  Analysis of APOE genotypes and allelic frequency (polymerase chain reaction) and plasma cholesterol concentration (enzymatic assay) were evaluated by a clinician blinded to the clinical diagnosis, and findings were compared between the groups with PDD or PD without dementia. Multiple stepwise regression analysis and the Spearman rank correlation coefficient were used to evaluate relationships between dementia and both APOE polymorphism and cholesterol concentration. Statistical significance was set at P<.05.

Results  4 Allele frequencies were similar in PDD and PD without dementia (16.8% vs 19%, respectively). Cholesterol concentration, APOE genotypes, and allelic frequencies did not relate to PDD.

Conclusions  In contrast to Alzheimer disease, when PDD is carefully defined, it is clearly not associated with APOE polymorphisms or with a distinctive plasma cholesterol profile. Ongoing longitudinal follow-up with emphasis on autopsy recruitment will enable further analyses of biochemical alterations underlying PDD.

Author Affiliations: Departments of Neurology, Ageing, Degenerative and Cerebrovascular Diseases (Drs Jasinska-Myga, Opala, Ochudlo, and Gorzkowska) and Microbiology (Dr Tustanowski), Medical University of Silesia, and Division of Clinical Psychology, Central University Hospital (Mrs Tyrpa), Katowice, Poland; and Department of Neurological Science, Rush University Medical Center, Chicago, Ill (Dr Goetz).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

APOE Alleles in Parkinson Disease and Their Relationship to Cognitive Decline: A Population-based, Longitudinal Study
Kurz et al.
J Geriatr Psychiatry Neurol 2009;22:166-170.
ABSTRACT  

Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
Riddell et al.
J. Neurosci. 2008;28:11445-11453.
ABSTRACT | FULL TEXT